The Desk
PEPTIDE INTELLIGENCE
Deep dives, stack guides, vendor spotlights, and regulatory updates. Written by the Stacked editorial desk — no sponsorship deals, no rewritten press releases, no medical advice.
4 articles · for research purposes only
Featured
BPC-157 and the Cancer Question: What the SRS Episode Missed
Louisa Nicola raised a real concern about BPC-157 and angiogenesis on SRS #300. The clip economy turned a 'we don't know' into 'BPC-157 causes cancer.' Here's the whole picture — including the 2025 peer-reviewed review most clips left out.
Latest
3 entries
Retatrutide in 2026: Where the Science Actually Stands
Retatrutide's 2026 status — Phase 3 TRIUMPH program, ~24% Phase 2 weight loss, MASH hepatic-fat data, regulatory timeline, and the current research-chemical market across tracked vendors.
Best Places to Buy Peptides Online in 2026: The Honest Review
An honest review of the best places to buy peptides online in 2026 — scored against our published methodology, with pricing, pros, cons, and red flags for every tracked vendor.
Tirzepatide vs Semaglutide vs Retatrutide: The Complete 2026 Comparison
Tirzepatide vs semaglutide vs retatrutide — a clinical, trial-grounded 2026 comparison of the three GLP-1 class peptides on efficacy, safety, availability, and cost.